Current Advances in Nanobiomaterials as Nanomedicine for Oncology
摘要
Nanotechnology has brought a revolution in the field of cancer detection and its treatment by enhancing drug delivery and improving therapeutic outcomes. Traditional therapies like surgery, radiotherapy, and chemotherapy face challenges like toxicity and drug resistance. On the other hand, Nanomedicine offers precision delivery, reducing the side effects and improving therapeutic efficacy. Nanomaterials, including carbon-based nanomaterials, liposomes, dendrimers, and metallic nanoparticles, play an important role in cancer theranostics, imaging, and drug delivery. The potential of nanomaterials in oncology is highlighted by the advances in targeting the tumor microenvironment, combination therapy, and immunotherapy. The chapter investigates the current advancements in clinical translation and the future directions for the use of nanotechnology in oncology, such as precision medicine and nanorobotics.